Dr Jonas Lanz (University of Bern, Bern, SW)
discusses - SCOPE-I: A Randomized Trial of the ACURATE neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis.
1. What is the SCOPE-I study?
2. What were your findings?
3. What were the stroke rates?
4. Is the ACURATE neo option still a valuable option to implanters?
Filmed on site at TCT 2019 by Radcliffe CardiologyVideographer: Josh Birch
Interviewer: Liam O’Neill